Skip to main content
Clinical Trials/NCT03400969
NCT03400969UnknownNot Applicable

A Randomized Controlled Trial of the Effectiveness of Three Different Oral Moisturizers in Palliative Care Patients.

University of Bergen2 sites in 1 country30 target enrollmentStarted: March 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
30
Locations
2
Primary Endpoint
Subjective xerostomia

Study Overview

Brief Summary

This study compares the effectiveness of 3 different oral moisturizers; 17% watery solution of glycerol, OGT oral spray, Aequasyal, and a newly developed Product, Salient.

Detailed Description

Background:

A majority of patients in palliative care have problems with dry mouth caused by medication or as a direct result of the mortal condition. Dry mouth will cause a variety of problems that commonly affect the disease negatively and contribute to reduced quality of life in the patient's last stage of life. A Cochrane review from 2011 concludes that "there are several moisturising agents available, but no strong evidence that any topical therapy is effective for relieving the symptom of dry mouth." It also concludes that "Oxygenated glycerol triester (OGT) oral spray is more effective than an aqueous electrolyte spray."1

Objectives:

To compare the effectiveness of 3 different oral moisturisers, ; 17 % watery solution of glycerol, OGT oral spray, Aequasyal® and a newly developed product, Salient®.

Methods/design:

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

A Block randomisation is made by a person, other than the one who applies the product. Neither the patient nor the person who records the product or the person who registers data knows which product is used for the intervention. The product is not labeled with name

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • The patients have xerostomia (subjective feeling of dry mouth). 2
  • The patients are palliative and in institutionalized care.
  • Curative treatment of existing diseases has been completed.
  • WHOs functional status 3/Karnofsky functional status 30 - 40 % (only capable of limited self-care, tied to bed or chair more than 50% of wake time).
  • Participants are cognitively functioning, capable of and willing to consent, capable of giving responses to a limited questionnaire and are expected to remain at the care centre for a minimum of 3 days.

Exclusion Criteria

  • Patients treated with radiotherapy in head and neck region.

Arms & Interventions

Glycerol 17 %

Active Comparator

Oral moisturizer

Intervention: Glycerol 17% (Device)

Aequasyal (OGT)

Active Comparator

Oral moisturizer

Intervention: Aequasyal (OGT) (Device)

Salient (new product)

Active Comparator

Oral moisturizer

Intervention: Salient (new product) (Device)

Outcomes

Primary Outcomes

Subjective xerostomia

Time Frame: 3 days

Measured on a 5-point Likert-scale: Subjective feeling of dry mouth: 1. Not dry 2. Insignificantly dry 3. Fairly dry 4. Almost completely dry 5. Completely dry

Secondary Outcomes

  • Speech(3 days)
  • Pain/discomfort(3 days)
  • Diurnal variation(3 days)
  • Situational dry mouth(3 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials